• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a method to predict in vivo drug metabolism and excretion from in vitro data with human hepatic tissues and/or recombinant proteins

Research Project

Project/Area Number 08557125
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Physical pharmacy
Research InstitutionGraduate School of Pharmaceutical Sciences, The University of Tokyo

Principal Investigator

SUGIYAMA Yuichi  Graduate School of Pharm.Sci., The Univ.of Tokyo Professor, 大学院・薬学系研究科, 教授 (80090471)

Co-Investigator(Kenkyū-buntansha) CHIBA Kan  Faculty of Pharmaceutical Sciences, Chiba University Professor, 薬学部, 教授 (40159033)
TAKIGAWA Hajime  School of Medicine, Teikyo University Professor, 医学部, 助教授 (70197226)
KATO Yukio  Graduate School of Pharm.Sci., The Univ.of Tokyo Research Associate, 大学院・薬学系研究科, 助手 (30251440)
SUZUKI Hiroshi  Graduate School of Pharm.Sci., The Univ.of Tokyo Assistant Professor, 大学院・薬学系研究科, 助教授 (80206523)
TERASAKI Tetsuya  Faculty of Pharmaceutical Sciences, Tohoku University Professor, 薬学部, 教授 (60155463)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥14,500,000 (Direct Cost: ¥14,500,000)
Fiscal Year 1997: ¥5,500,000 (Direct Cost: ¥5,500,000)
Fiscal Year 1996: ¥9,000,000 (Direct Cost: ¥9,000,000)
Keywordsdrug metabolism / hepatic microsomes / recombinant P-450 / transporter / hepatic uptake / biliary excretion / 胆管側膜小胞 / 能動輸送
Research Abstract

The content of the present study can be classified into two parts. Each part is described separately :
1. Quantitative prediction of in vivo metabolism from in vitro data with human microsomes/P-450 expressing system
By kinetically analyzing the previously reported data, we determined the metabolic activity determined with human microsomes in vitro and that determined in humans in vivo. We found a nice 1 : 1 correlation between the two parameters, suggesting that in vivo disposition can be extrapolated from in vitro data. In order to comfirm this conclusion, we also performed experiments with YM796, which is metabolized by CYP3A4 enzyme. Kinetic parameters (Km and Vmax) were determined in vitro with microsomes. These parameter values were further used in predicting the drug disposition in vivo after oral administration. In this prediction, dispersion model was used, in which the nonlinear metabolism was considered. By analyzing the disposition of YM796 after oral administration, we found … More that the in vivo disposition of this drug can be extrapolated from in vitro data. Moreover, we examined the metabolism of YM796 by using the microsomes from leukoblastoma transfected with CYP3A4 cDNA.It was indicated that the metabolic data with human microsomes can be predicted from the kineticparameters determined with the recombinant enzymes after correcting the amount of the isozymes in the human microsomes. These results suggest that the disposition in humans can be predicted from the data determined with the recombinant enzymes.
2. Determination of transport activity using the mammalian cells transfected with cDNA for transporters
By comparing the transport activity determined in isolated hepatocytes along with that determined in the cells transfected with the cloned cDNA for transporters, we determined the contribution of each transporter to the hepatic uptake of ligands. Moreover, we performed the genetic analysis of atransporter (canalicular multispecific organic anion transporter ; cMOAT) responsible for the excretion of organic anions into the bile. We had also examined the function of cloned cMOAT cDNA by preparing the stable transfectant. ATP-dependent uptake of 2,4-dinitrophenyl-S-glutathione, atypical substrate for cMOAT,into membrane vesicles isolated from NIH/3T3 cells was stimulated by transfection of rat cMOAT cDNA These results suggest that the methodology employed in the present study may be useful in the quantitative prediction of transport from the activity determined with the cloned cDNA products. Less

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] M. Yamazaki: "Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics" Pharm. Res.13. 497-513 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] K. Ito: "Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR" Am. J. Physiol.272. G16-G22 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] T. Iwatsubo: "Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data" Pharmacol. Ther.73 (2). 147-171 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] T. Iwatsubo: "Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes" J. Pharmacol. Exp. Ther.282 (2). 909-919 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] T. Iwatsubo: "Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data" J. Pharmacol. Exp. Ther.283 (2). 462-469 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] K. Ito: "Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver" J. Biol. Chem.273 (3). 1684-1688 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 鈴木洋史: "抗癌剤の相互作用" 医薬ジャーナル社(杉山雄一,佐々木康綱編), (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 楠原洋之: "抗癌剤の相互作用" 医薬ジャーナル社(杉山雄一,佐々木康綱編),

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] M.Yamazaki et al.: "Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics." Pharm.Res. (review). 13. 497-513 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] K.Ito et al.: "Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR" Am.J.Physiol.272. G16-G22 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] T.Iwatsubo et al.: "Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data." Pharmacol.Therap. (review). 73. 147-171 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] T.Iwatsubo et al.: "Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes" J.Pharmacol.Exp.Therap.282. 909-919 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] T.Iwatsubo et al.: "Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data" J.Pharmacol.Exp.Therap.283. 462-469 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] K.Ito et al.: "Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver" J.Biological Chemistry. 273. 1684-1688 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] T.Iwatsubo: "Prediction of in vivo drug metabolism in the human liver from in vitro metablism data" Pharmacol.Ther.73(2). 147-171 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] T.Iwatsubo: "Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes." J.Pharmacol.Exp.Ther.282(2). 909-919 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] T.Iwatsubo: "^1Prediction of species differences (rats,dogs,humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data." J.Pharmacol.Exp.Ther.283(2). 462-469 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] H.Sasabe: "Carrier-mediated hepatic uptake of quinclone antibiotics in the rat." J.Pharmacol.Exp.Ther.282(1). 162-171 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] M.Yamazaki: "Biliary excretion of pravastatin in rats:contribution of the excretion pathway mediated by canalicutar mults:specific organic anion trans porter c(MOAF)." Drug Metab Dispos.25(10). 1123-1129 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] K.Ito: "Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver" J.Biol.Chem.273(3). 1684-1688 (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] T.Iwatsubo: "Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics." Biopharm.Drug & Disposit.17. 273-310 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] M.Yamazaki: "Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics." Pharm.Res.13. 497-513 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] K.Ito: "Expression of a putative ATP-binding cassette region,homologous tothat in multidrug resistance associated protein(MRP),is hereditarily defective in Eisai hyperbilirubinemic rats(EHBR)." Int.Hepatol.Commun.4. 292-299 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] K.Ito: "Molecular cloning of canalicular multispecific organic anion transporter defective in Eisai hyperbilirubinemic rats." Am.J.Physiol.272. G16-G22 (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] H.Ishizuka: "Temocapril,a novel angiotensin converting enzyme inhibitor,is excreted into bile via an ATP-dependent active transporter(cMOAT)that is deficient in Eisai hyperbilirubinemic mutant rats(EHBR)" J.Pharmacol.Exp.Ther.in press. 280. (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] O.Takenaka: "Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethy 1-2-methylamino-4-(3-pyridylmethyl)benzothiazolle(E3040)into rat liver:Quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo." J.Pharmacol.Exp.Ther.in press. 280. (1997)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi